Hepatocellular Carcinoma Drugs Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Financial Impact Analysis)
ID : MRU_
3563 | Date :
Jan, 2023 | Pages :
192 | Region : Global |
Publisher : 99 Strategy
HCC is the most common form of primary liver cancer in adults and occurs mainly in the patients with underlying liver disease and cirrhosis. The disease originates in the liver unlike the secondary liver cancers which reaches to the liver from other organs of the body. Currently only two drugs NEXAVAR and STIVARGA are approved for the treatment of the disease.
The incidence rate of hepatic cancer such as intrahepatic bile duct cancer in U.S. was approximately 39,230 during 2019. The risk factors associated with hepatocellular carcinoma are Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection, alcoholic cirrhosis, metabolic syndrome, biliary cirrhosis, and chronic liver injury. The advancement in technology, personalized medicine, cost effective treatment procedures are few other factors predicted to keep up the growth of global hepatocellular carcinoma treatment market. However, side effects associated with the chemotherapy, high cost of treatment are some of the major restraints limiting the growth of global hepatocellular carcinoma treatment market.
The Global Hepatocellular Carcinoma Drugs Market touched xxx million USD with a CAGR xx % from 2018-2022 around the world. In the future, it is predicted to reach xxx million USD in 2023 with a CAGR xx % from 2023-2030.
As the report focuses on global Hepatocellular Carcinoma Drugs Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies-
Bayer
Eli Lilly
Johnson and Johnson
Pfizer
Bristol-Myers Squibb
Celgene
F. Hoffmann-la Roche
Gilead
GlaxoSmithKline
Merck
Novartis
In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers:
Brachytherapy
Chemotherapy
Local Ablation Therapy
In Market segmentation by applications :
Hospitals
Clinics
Cancer Rehabilitation Centers
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Hepatocellular Carcinoma Drugs Market for the forecast period 2023-2030?
• What are the driving forces in the Hepatocellular Carcinoma Drugs Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Hepatocellular Carcinoma Drugs industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Hepatocellular Carcinoma Drugs Market Size Growth Rate by Type (2020-2030)
1.3.2 Brachytherapy
1.3.3 Chemotherapy
1.3.4 Local Ablation Therapy
1.4 Market Segment by Application
1.4.1 Global Hepatocellular Carcinoma Drugs Market Share by Application (2020-2030)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Cancer Rehabilitation Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatocellular Carcinoma Drugs Market Size
2.1.1 Global Hepatocellular Carcinoma Drugs Revenue 2015-2030
2.1.2 Global Hepatocellular Carcinoma Drugs Sales 2015-2030
2.2 Hepatocellular Carcinoma Drugs Growth Rate by Regions
2.2.1 Global Hepatocellular Carcinoma Drugs Sales by Regions 2018 - 2022
2.2.2 Global Hepatocellular Carcinoma Drugs Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Hepatocellular Carcinoma Drugs Sales by Manufacturers
3.1.1 Hepatocellular Carcinoma Drugs Sales by Manufacturers 2018 - 2022
3.1.2 Hepatocellular Carcinoma Drugs Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 Hepatocellular Carcinoma Drugs Revenue by Manufacturers (2018 - 2022)
3.2.2 Hepatocellular Carcinoma Drugs Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Hepatocellular Carcinoma Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Hepatocellular Carcinoma Drugs Price by Manufacturers
3.4 Key Manufacturers Hepatocellular Carcinoma Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Hepatocellular Carcinoma Drugs Market
3.6 Key Manufacturers Hepatocellular Carcinoma Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Brachytherapy Sales and Revenue (2018 - 2022)
4.1.2 Chemotherapy Sales and Revenue (2018 - 2022)
4.1.3 Local Ablation Therapy Sales and Revenue (2018 - 2022)
4.2 Global Hepatocellular Carcinoma Drugs Sales Market Share by Type
4.3 Global Hepatocellular Carcinoma Drugs Revenue Market Share by Type
4.4 Hepatocellular Carcinoma Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Hepatocellular Carcinoma Drugs Sales by Application
6 United States
6.1 United States Hepatocellular Carcinoma Drugs Breakdown Data by Company
6.2 United States Hepatocellular Carcinoma Drugs Breakdown Data by Type
6.3 United States Hepatocellular Carcinoma Drugs Breakdown Data by Application
7 European Union
7.1 European Union Hepatocellular Carcinoma Drugs Breakdown Data by Company
7.2 European Union Hepatocellular Carcinoma Drugs Breakdown Data by Type
7.3 European Union Hepatocellular Carcinoma Drugs Breakdown Data by Application
8 China
8.1 China Hepatocellular Carcinoma Drugs Breakdown Data by Company
8.2 China Hepatocellular Carcinoma Drugs Breakdown Data by Type
8.3 China Hepatocellular Carcinoma Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Hepatocellular Carcinoma Drugs Breakdown Data by Company
9.2 Rest of World Hepatocellular Carcinoma Drugs Breakdown Data by Type
9.3 Rest of World Hepatocellular Carcinoma Drugs Breakdown Data by Application
9.4 Rest of World Hepatocellular Carcinoma Drugs Breakdown Data by Countries
9.4.1 Rest of World Hepatocellular Carcinoma Drugs Sales by Countries
9.4.2 Rest of World Hepatocellular Carcinoma Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.1.4 Hepatocellular Carcinoma Drugs Product Introduction
10.1.5 Bayer Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.2.4 Hepatocellular Carcinoma Drugs Product Introduction
10.2.5 Eli Lilly Recent Development
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.3.4 Hepatocellular Carcinoma Drugs Product Introduction
10.3.5 Johnson and Johnson Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.4.4 Hepatocellular Carcinoma Drugs Product Introduction
10.4.5 Pfizer Recent Development
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.5.4 Hepatocellular Carcinoma Drugs Product Introduction
10.5.5 Bristol-Myers Squibb Recent Development
10.6 Celgene
10.6.1 Celgene Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.6.4 Hepatocellular Carcinoma Drugs Product Introduction
10.6.5 Celgene Recent Development
10.7 F. Hoffmann-la Roche
10.7.1 F. Hoffmann-la Roche Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.7.4 Hepatocellular Carcinoma Drugs Product Introduction
10.7.5 F. Hoffmann-la Roche Recent Development
10.8 Gilead
10.8.1 Gilead Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.8.4 Hepatocellular Carcinoma Drugs Product Introduction
10.8.5 Gilead Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.9.4 Hepatocellular Carcinoma Drugs Product Introduction
10.9.5 GlaxoSmithKline Recent Development
10.10 Merck
10.10.1 Merck Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Hepatocellular Carcinoma Drugs
10.10.4 Hepatocellular Carcinoma Drugs Product Introduction
10.10.5 Merck Recent Development
10.11 Novartis
12 Market Forecast
12.1 Global Hepatocellular Carcinoma Drugs Sales and Revenue Forecast 2020-2030
12.2 Global Hepatocellular Carcinoma Drugs Sales Forecast by Type
12.3 Global Hepatocellular Carcinoma Drugs Sales Forecast by Application
12.4 Hepatocellular Carcinoma Drugs Forecast by Regions
12.4.1 Global Hepatocellular Carcinoma Drugs Sales Forecast by Regions 2020-2030
12.4.2 Global Hepatocellular Carcinoma Drugs Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
